Hospital
Luminis Health Doctors Community Medical Center, INC.
Luminis Health Doctors Community Medical Center, INC. was paid $9.88M by Medicaid between Jan 2018 and Nov 2024, across 114 billing codes. Its largest line is 99284, emergency room visit (serious) — 29% of everything it billed.
33Billing provider infoLUMINIS HEALTH DOCTORS COMMUNITY MEDICAL CENTER, INC.
LANHAM, MD 20706
LANHAM, MD 20706
33aNPI1730136532assigned 05/27/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.88M
24GClaims156,534
24DCodes billed114
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Maryland
Rank by total paid#3 of 69
Median peer was paid$870K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 35,413 | $2.33M | |
| 2019 | 39,726 | $2.32M | |
| 2020 | 21,079 | $1.10M | |
| 2021 | 22,071 | $1.51M | |
| 2022 | 17,980 | $1.37M | |
| 2023 | 11,755 | $699K | |
| 2024incomplete | 8,510 | $552K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 29% | 11,966 | 10,764 | $2.84M |
| G0378 | Hospital observation service, per hour | 24% | 3,220 | 2,841 | $2.41M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.5% | 6,088 | 5,619 | $937K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 6.9% | 11,150 | 9,591 | $685K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.2% | 1,852 | 1,693 | $511K |
| 80053 | Comprehensive metabolic panel | 2.4% | 14,828 | 12,746 | $237K |
| 84484 | 1.9% | 8,318 | 6,193 | $192K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 2,000 | 1,862 | $189K |
| 71046 | Radiologic examination, chest; 2 views | 1.8% | 4,088 | 3,756 | $176K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 17,064 | 13,640 | $160K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.4% | 1,149 | 739 | $141K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.4% | 921 | 870 | $136K |
102 more codes
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.2% | 854 | $119K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.2% | 4,694 | $115K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,180 | $88K |
| 81001 | <1% | 7,308 | $73K | |
| 87400 | <1% | 725 | $71K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,337 | $71K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,969 | $67K |
| 74178 | <1% | 752 | $66K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 90 | $48K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,190 | $40K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,631 | $36K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 455 | $35K |
| 84703 | <1% | 1,888 | $33K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,210 | $29K |
| 83690 | <1% | 3,271 | $28K | |
| 87040 | <1% | 391 | $27K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 249 | $24K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 103 | $23K |
| 84702 | <1% | 324 | $17K | |
| 80306 | <1% | 136 | $15K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 420 | $14K |
| 87070 | <1% | 302 | $14K | |
| 83880 | <1% | 971 | $12K | |
| 81003 | <1% | 2,436 | $12K | |
| 81025 | <1% | 716 | $11K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 146 | $10K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 138 | $9K |
| 87077 | <1% | 649 | $9K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,081 | $8K |
| 85027 | <1% | 1,302 | $8K | |
| 93971 | <1% | 45 | $8K | |
| J1815 | Injection, insulin, per 5 units | <1% | 853 | $6K |
| 85379 | <1% | 305 | $6K | |
| 87430 | <1% | 171 | $6K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 94 | $6K |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 30 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,090 | $5K |
| 73562 | <1% | 60 | $5K | |
| 86850 | <1% | 482 | $5K | |
| 82948 | <1% | 2,099 | $5K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 16 | $5K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,527 | $4K |
| 85730 | <1% | 975 | $4K | |
| 85610 | <1% | 1,342 | $4K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 16 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 236 | $3K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 16 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 58 | $3K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 296 | $3K |
| 80305 | <1% | 17 | $3K | |
| 87186 | <1% | 416 | $3K | |
| 83605 | <1% | 182 | $3K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 12 | $2K |
| 87210 | <1% | 114 | $2K | |
| 76000 | <1% | 17 | $2K | |
| 87581 | <1% | 16 | $2K | |
| 87486 | <1% | 16 | $2K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 13 | $2K |
| 86900 | <1% | 559 | $2K | |
| 86901 | <1% | 517 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,231 | $2K |
| G0257 | Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility | <1% | 15 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 12 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,000 | $1K |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 437 | $1K |
| 85014 | <1% | 336 | $1K | |
| 73130 | <1% | 19 | $1K | |
| 73630 | <1% | 19 | $981.95 | |
| 80320 | <1% | 32 | $972.78 | |
| 94760 | <1% | 174 | $748.96 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 43 | $676.20 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 12 | $643.20 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 209 | $631.16 |
| J3490 | Unclassified drugs | <1% | 214 | $624.95 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 268 | $618.77 |
| 85018 | <1% | 270 | $478.83 | |
| 72100 | <1% | 12 | $457.16 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 432 | $444.71 |
| 94664 | <1% | 249 | $425.42 | |
| 83735 | <1% | 161 | $411.43 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 43 | $411.01 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 333 | $366.18 |
| 84132 | <1% | 204 | $363.85 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 234 | $339.08 |
| 82077 | <1% | 13 | $283.52 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 528 | $173.94 |
| 81015 | <1% | 44 | $169.19 | |
| 80061 | Lipid panel | <1% | 17 | $164.88 |
| 82435 | <1% | 104 | $150.67 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 268 | $146.14 |
| 84520 | <1% | 103 | $124.07 | |
| 87088 | <1% | 12 | $116.81 | |
| 84295 | <1% | 102 | $91.21 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 64 | $61.97 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 644 | $23.41 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 19 | $12.20 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 29 | $10.76 |
| 82565 | 0% | 13 | $0.00 | |
| 82248 | 0% | 14 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 338 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 39 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 72 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVELLEN, JASON (DIRECTOR, PATIENT FINANCIAL SERVICE)
| Provider | Location | Paid |
|---|---|---|
| Luminis Health Anne Arundel Medical Center, INC. | Annapolis, MD | $2.58M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.